Should Evidence-Based Proof of Efficacy as Defined for a Specific Therapeutic Agent Be Extrapolated to Encompass a Therapeutic Class of Agents?
Circulation - United States
doi 10.1161/01.cir.0000090571.83005.ce
Full Text
Open PDFAbstract
Available in full text
Date
November 25, 2003
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)